<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>21(1)</volume><submitter>Hu Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>RNA-binding motif protein 14 (RBM14) is upregulated in a variety of tumors. However, the expression and biological role of RBM14 in lung cancer remain unclear.&lt;h4>Methods&lt;/h4>Chromatin immunoprecipitation and PCR were carried out to measure the levels of sedimentary YY1, EP300, H3K9ac, and H3K27ac in the RBM14 promoter. Co-immunoprecipitation was used to verify the interaction between YY1 and EP300. Glycolysis was investigated according to glucose consumption, lactate production, and the extracellular acidification rate (ECAR).&lt;h4>Results&lt;/h4>RBM14 level is increased in lung adenocarcinoma (LUAD) cells. The increased RBM14 expression was correlated with TP53 mutation and individual cancer stages. A high level of RBM14 predicted a poorer overall survival of LUAD patients.</pubmed_abstract><journal>World journal of surgical oncology</journal><pagination>132</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10105460</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>RBM14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer.</pubmed_title><pmcid>PMC10105460</pmcid><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Mu H</pubmed_authors><pubmed_authors>Deng Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>RBM14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer.</name><description>&lt;h4>Background&lt;/h4>RNA-binding motif protein 14 (RBM14) is upregulated in a variety of tumors. However, the expression and biological role of RBM14 in lung cancer remain unclear.&lt;h4>Methods&lt;/h4>Chromatin immunoprecipitation and PCR were carried out to measure the levels of sedimentary YY1, EP300, H3K9ac, and H3K27ac in the RBM14 promoter. Co-immunoprecipitation was used to verify the interaction between YY1 and EP300. Glycolysis was investigated according to glucose consumption, lactate production, and the extracellular acidification rate (ECAR).&lt;h4>Results&lt;/h4>RBM14 level is increased in lung adenocarcinoma (LUAD) cells. The increased RBM14 expression was correlated with TP53 mutation and individual cancer stages. A high level of RBM14 predicted a poorer overall survival of LUAD patients.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-05-29T14:37:41.591Z</modification><creation>2024-10-19T01:47:24.839Z</creation></dates><accession>S-EPMC10105460</accession><cross_references><pubmed>37060064</pubmed><doi>10.1186/s12957-023-02928-8</doi></cross_references></HashMap>